Paper16614977
Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
Rost D and 3 others. Dig Dis Sci, 2006. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. Papers, record 16614977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16614977
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholangitis, Sclerosing | Major topic |
| Colitis | Major topic |
| Colonic Pouches | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Adult | |
| Bile Acids and Salts | |
| Case-Control Studies | |
| Dose-Response Relationship, Drug | |
| Drug Administration Schedule | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Maximum Tolerated Dose | |
| Probability | |
| Reference Values | |
| Risk Assessment | |
| Treatment Outcome |
Source PubMed
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 8259039 | Taurine conjugate of ursodeoxycholate plays a major role in the hepatoprotective effect against cholestasis induced by taurochenodeoxycholate in rats. | Liver | 1993 | https://conductscience.org/library/papers/8259039 | PubMed |
| 2 | 1959845 | Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. | Hepatology | 1991 | https://conductscience.org/library/papers/1959845 | PubMed |
| 3 | 1537519 | Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage. | Gastroenterology | 1992 | https://conductscience.org/library/papers/1537519 | PubMed |
| 4 | 9287980 | Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. | Gastroenterology | 1997 | https://conductscience.org/library/papers/9287980 | PubMed |
| 5 | 7435569 | Metabolism in man of 7-ketolithocholic acid: precursor of cheno- and ursodeoxycholic acids. | Am J Physiol | 1980 | https://conductscience.org/library/papers/7435569 | PubMed |
| 6 | 11830325 | Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment. | J Hepatol | 2002 | https://conductscience.org/library/papers/11830325 | PubMed |
| 7 | 10510466 | Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. | Cell Death Differ | 1999 | https://conductscience.org/library/papers/10510466 | PubMed |
| 8 | 9918905 | Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. | Hepatology | 1999 | https://conductscience.org/library/papers/9918905 | PubMed |
| 9 | 9537871 | Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. | J Hepatol | 1998 | https://conductscience.org/library/papers/9537871 | PubMed |
| 10 | 2777202 | Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Hepatology | 1989 | https://conductscience.org/library/papers/2777202 | PubMed |
| 11 | 2295398 | Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. | Gastroenterology | 1990 | https://conductscience.org/library/papers/2295398 | PubMed |
| 12 | 864325 | Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. | J Lipid Res | 1977 | https://conductscience.org/library/papers/864325 | PubMed |
| 13 | 1983822 | Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. | Gastroenterology | 1991 | https://conductscience.org/library/papers/1983822 | PubMed |
| 14 | 1505913 | Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. | Hepatology | 1992 | https://conductscience.org/library/papers/1505913 | PubMed |
| 15 | 10347103 | Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid. | Hepatology | 1999 | https://conductscience.org/library/papers/10347103 | PubMed |
| 16 | 2401454 | Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Hepatology | 1990 | https://conductscience.org/library/papers/2401454 | PubMed |
| 17 | 8174892 | Ursodeoxycholate conjugates protect against disruption of cholesterol-rich membranes by bile salts. | Gastroenterology | 1994 | https://conductscience.org/library/papers/8174892 | PubMed |
| 18 | 15349909 | Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. | Hepatology | 2004 | https://conductscience.org/library/papers/15349909 | PubMed |
| 19 | 10219843 | Influence of cholestasis on absorption of ursodeoxycholic acid. | Dig Dis Sci | 1999 | https://conductscience.org/library/papers/10219843 | PubMed |
| 20 | 2391610 | Effects of ursodeoxycholic acid therapy for liver disease associated with cystic fibrosis. | J Pediatr | 1990 | https://conductscience.org/library/papers/2391610 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 20564380 | Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. | Hepatology | 2010 | https://conductscience.org/library/papers/20564380 | PubMed |
| 17391626 | Treatment of primary sclerosing cholangitis. | Curr Treat Options Gastroenterol | 2007 | https://conductscience.org/library/papers/17391626 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16614977
GET https://conductscience.org/api/papers/v1/16614977/references?page=2